Biotech Archives - Page 675 of 795

1 minute read

Amneal Pharmaceuticals Announces Commercial Launch Of ALYMSYS

October 3, 4:09 PM

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) (“Amneal” or the “Company”) today announced the commercial launch of ALYMSYS® (bevacizumab-maly), a biosimilar referencing Avastin®. ALYMSYS®

AMRX

1 minute read

Theratechnologies’ Trogarzo Approved By FDA For 30-Second Intravenous (IV) Push, Simplifying HIV Treatment For Heavily Treatment-Experienced Population

By Benzinga Newsdesk

October 3, 3:10 PM

Reduces maintenance dose from a 15-minute IV infusion to a 30-second, undiluted IV push every two weeks Safety profile of Trogarzo® IV push similar to that of IV infusion New method of

THTX

1 minute read

Aclarion Has Received A Notice Of Allowance For Its U.S. Patent Application 16/224,590 Titled “Magnetic Resonance Spectroscopy System And Method For Diagnosing Pain Or Infection Associated With Propionic Acid” – Patent Center

By Benzinga Newsdesk

October 3, 2:16 PM

https://patentcenter.uspto.gov/applications/16224590/ifw/docs

ACON

1 minute read

US Supreme Court Turns Away Biogen’s Last Effort To Reinstate Tecfidera Patent

By Vandana Singh

October 3, 2:14 PM

The U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen Inc's (NASDAQ: BIIB) blockbuster drug Tecfidera.

BIIB

2 minute read

Aura Biosciences Details Interim Data From Mid-Stage Study Of Ocular Oncology Drug

By Vandana Singh

October 3, 1:37 PM

Aura Biosciences Inc (NASDAQ:AURA) detailed interim data from its ongoing Phase 2 trial of an eye cancer drug, elzupacap sarotalocan (AUâ€‘011).…

AURA

1 minute read

Clovis Oncology’s Rubraca Hits Primary Goal In Prostate Cancer Settings

By Vandana Singh

October 3, 1:35 PM

Clovis Oncology Inc (NASDAQ:CLVS) announced topline data from the Phase 3 TRITON3 trial, demonstrating that Rubraca monotherapy treatment significantly improved radiographic…

CLVS

1 minute read

BioCardia’s Heart Failure Cell Therapy Shows 100% Survival At Two Years

By Vandana Singh

October 3, 1:33 PM

BioCardia Inc (NASDAQ:BCDA) announced data from its CardiAMP Cell Therapy for Heart Failure pivotal trial. “The two-year outcomes for patients with…

BCDA

1 minute read

Investigator Says Apellis’ Lead Product Shows ‘First Direct Evidence Of Slowing Geographic Atrophy Lesion Growth’

By Vandana Singh

October 3, 11:38 AM

Apellis Pharmaceuticals Inc (NASDAQ:APLS) announced new data from the 24-month Phase 3 OAKS study of pegcetacoplan for geographic atrophy (GA) secondary…

APLS

1 minute read

RedHill Biopharma Says Its Oral Broad-Acting Antivirals Inhibit Dominant Omicron Sub-Variant BA.5

By Vandana Singh

October 3, 11:20 AM

RedHill Biopharma Ltd (NASDAQ:RDHL) announced study results showing in vitro efficacy against the currently dominant omicron COVID-19 sub-variant BA.5, by both…

RDHL

1 minute read

FDA
News

FDA Releases Important Information About Risk Of Covid-19 Due To Certain Variants Not Neutralized By Evusheld

By Benzinga Newsdesk

October 3, 11:10 AM

-Reuters

AZN